Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.
Morgenstern DA, London WB, Stephens D, Volchenboum SL, Hero B, Di Cataldo A, Nakagawara A, Shimada H, Ambros PF, Matthay KK, Cohn SL, Pearson AD, Irwin MS. Morgenstern DA, et al. Among authors: pearson ad. J Clin Oncol. 2014 Apr 20;32(12):1228-35. doi: 10.1200/JCO.2013.53.6342. Epub 2014 Mar 24. J Clin Oncol. 2014. PMID: 24663047 Free PMC article. Clinical Trial.
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.
Ladenstein R, Philip T, Lasset C, Hartmann O, Garaventa A, Pinkerton R, Michon J, Pritchard J, Klingebiel T, Kremens B, Pearson A, Coze C, Paolucci P, Frappaz D, Gadner H, Chauvin F. Ladenstein R, et al. J Clin Oncol. 1998 Mar;16(3):953-65. doi: 10.1200/JCO.1998.16.3.953. J Clin Oncol. 1998. PMID: 9508178
Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year.
Burchill SA, Lewis IJ, Abrams KR, Riley R, Imeson J, Pearson AD, Pinkerton R, Selby P. Burchill SA, et al. Among authors: pearson ad. J Clin Oncol. 2001 Mar 15;19(6):1795-801. doi: 10.1200/JCO.2001.19.6.1795. J Clin Oncol. 2001. PMID: 11251011
Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors.
Lastowska M, Cullinane C, Variend S, Cotterill S, Bown N, O'Neill S, Mazzocco K, Roberts P, Nicholson J, Ellershaw C, Pearson AD, Jackson MS; United Kingdom Children Cancer Study Group and the United Kingdom Cancer Cytogenetics Group. Lastowska M, et al. Among authors: pearson ad. J Clin Oncol. 2001 Jun 15;19(12):3080-90. doi: 10.1200/JCO.2001.19.12.3080. J Clin Oncol. 2001. PMID: 11408505
17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
Bown N, Lastowska M, Cotterill S, O'Neill S, Ellershaw C, Roberts P, Lewis I, Pearson AD; U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group. Bown N, et al. Among authors: pearson ad. Med Pediatr Oncol. 2001 Jan;36(1):14-9. doi: 10.1002/1096-911X(20010101)36:1<14::AID-MPO1005>3.0.CO;2-G. Med Pediatr Oncol. 2001. PMID: 11464868
Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group.
George RE, Variend S, Cullinane C, Cotterill SJ, McGuckin AG, Ellershaw C, Lunec J, Pearson AD; United Kingdom Children Cancer Study Group. George RE, et al. Among authors: pearson ad. Med Pediatr Oncol. 2001 Jan;36(1):169-76. doi: 10.1002/1096-911X(20010101)36:1<169::AID-MPO1041>3.0.CO;2-U. Med Pediatr Oncol. 2001. PMID: 11464876 Review.
Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: a report from the European Neuroblastoma Study Group "Survey".
Cotterill SJ, Pearson AD, Pritchard J, Kohler JA, Foot AB; European Neuroblastoma Study Group and United Kingdom Children's Cancer Study Group. Cotterill SJ, et al. Among authors: pearson ad. Med Pediatr Oncol. 2001 Jan;36(1):235-8. doi: 10.1002/1096-911X(20010101)36:1<235::AID-MPO1057>3.0.CO;2-N. Med Pediatr Oncol. 2001. PMID: 11464893
High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial.
Pearson AD, Pinkerton CR, Lewis IJ, Imeson J, Ellershaw C, Machin D; European Neuroblastoma Study Group; Children's Cancer and Leukaemia Group (CCLG formerly United Kingdom Children's Cancer Study Group). Pearson AD, et al. Lancet Oncol. 2008 Mar;9(3):247-56. doi: 10.1016/S1470-2045(08)70069-X. Lancet Oncol. 2008. PMID: 18308250 Clinical Trial.
Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.
Bagatell R, Beck-Popovic M, London WB, Zhang Y, Pearson AD, Matthay KK, Monclair T, Ambros PF, Cohn SL; International Neuroblastoma Risk Group. Bagatell R, et al. Among authors: pearson ad. J Clin Oncol. 2009 Jan 20;27(3):365-70. doi: 10.1200/JCO.2008.17.9184. Epub 2008 Dec 1. J Clin Oncol. 2009. PMID: 19047282 Free PMC article.
399 results